ProPhase Labs, Inc.

ProPhase Labs, Inc.

OOTC:PRPH
0.01
USD
+0.00
(+2.67%)
-2.28EPS
1.29MMarket Cap

Total Valuation

USD

As of June 30, 2026, ProPhase Labs, Inc. carries a market capitalization of 1.29M, placing it among publicly traded companies globally. Its enterprise value stands at 10.39M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap1.29M
Enterprise Value10.39M

Important Dates

ProPhase Labs, Inc.'s next confirmed earnings release is scheduled for November 16, 2026.

Earnings Date11/16/2026

Share Statistics

As of June 30, 2026, ProPhase Labs, Inc. has 14.02M shares outstanding.

Shares Outstanding14.02M

Valuation Ratios

These figures are as of June 30, 2026. The price-to-sales ratio is 0.24, and the price-to-book ratio stands at -0.41.

PS Ratio0.24
PB Ratio-0.41
P/TBV Ratio-0.10
P/FCF Ratio-0.16
P/OCF Ratio-0.16

Enterprise Valuation

These figures are as of June 30, 2026. The EV/Sales ratio of 2.70 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 10.39M versus a market cap of 1.29M, with the gap driven by net debt and cash on the balance sheet.

EV / Sales2.70

Financial Position

As of June 30, 2026, ProPhase Labs, Inc. maintains a current ratio of 0.05, meaning it holds 0.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -293.15, indicating conservative leverage, while an interest coverage ratio of -1.60 demonstrates limited ability to service its debt obligations.

Current Ratio0.05
Quick Ratio0.03
Debt / Equity-293.15
Debt / EBITDA-0.78
Interest Coverage-1.60

Financial Efficiency

USD

These figures cover the twelve months ended June 30, 2026. Return on assets (ROA) is negative at -45.17, reflecting losses generated across the asset base. The company generates approximately 100,575.16 in revenue per employee across its workforce of 38.25, a quick read on workforce productivity versus industry peers. Inventory turnover of 7.12 indicates how many times ProPhase Labs, Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Return on Assets (ROA)-45.17
Revenue Per Employee100,575.16
Employee Count38.25
Inventory Turnover7.12

Taxes

USD

Over the twelve months ended June 30, 2026, ProPhase Labs, Inc. recorded 607,000.00 in income tax expense. The company reported a pretax loss of -21.86M and -22.46M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

Income Tax607,000.00

Stock Price Statistics

USD

As of the close on November 16, 2026, ProPhase Labs, Inc.'s stock has declined approximately 99.98% over the past 52 weeks. The 50-day moving average sits at 0.01, while the 200-day moving average is 0.08.

52-Week Price Change-99.98%
50-Day Moving Average0.01
200-Day Moving Average0.08

Income Statement

USD

Over the twelve months ended June 30, 2026, ProPhase Labs, Inc. generated 3.85M in revenue and converted that into -22.46M in net income, yielding earnings per share of -2.28. EBITDA reached -11.62M, while operating income came in at -15.56M.

Revenue3.85M
Gross Profit645,000.00
Operating Income-15.56M
Pretax Income-21.86M
Net Income-22.46M
EBITDA-11.62M
EBIT-15.56M
Earnings Per Share (EPS)-2.28

Balance Sheet

USD

As of June 30, 2026, ProPhase Labs, Inc. holds 20,000.00 in cash and equivalents against 9.12M in total debt, resulting in a net debt position of 5.57M. Total book value stands at -3.11M, with working capital of -55.28M providing operational flexibility.

Cash & Cash Equivalents20,000.00
Total Debt9.12M
Net Debt5.57M
Equity (Book Value)-3.11M
Book Value Per Share-0.22
Working Capital-55.28M

Cash Flow

USD

ProPhase Labs, Inc. produced -5.54M in operating cash flow over the twelve months ended June 30, 2026.

Operating Cash Flow-5.54M
Free Cash Flow-5.54M
FCF Per Share-0.56

Margins

Over the twelve months ended June 30, 2026, ProPhase Labs, Inc. posted a gross margin of 16.77, reflecting its pricing power and cost economics. The operating margin of -404.50 and net profit margin of -583.91 provide insight into operational efficiency.

Gross Margin16.77
Operating Margin-404.50
Pretax Margin-568.13
Profit Margin-583.91
EBITDA Margin-302.00

Dividends & Yields

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -610.74: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -417.30, meaning ProPhase Labs, Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Shareholder Yield-417.30
FCF Yield-610.74

Stock Splits

ProPhase Labs, Inc.'s most recent stock split took place on December 22, 2025 with a 10:1 split ratio.

Last Split Date12/22/2025
Split Ratio10:1

Scores

As of June 30, 2026, ProPhase Labs, Inc. has an Altman Z-Score of -4.78, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-4.78